SALT LAKE CITY, Feb. 15, 2011 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that its board of directors has approved a $1 million open market share repurchase program of the company's common stock.
"This decision reflects the confidence of management and our board of directors in the future of the company and our commitment to increasing shareholder value," said Kelvyn H. Cullimore, president of Dynatronics. "Based on recent announcements of contract awards with large group purchasing organizations and other anticipated opportunities, we expect to see revenues continue to grow over the next two years. Based on this outlook and other factors, this newly authorized $1 million share repurchase plan provides us with the flexibility, when market conditions warrant, to reduce our outstanding shares and offset potential future dilution from awards under our equity-based compensation plans." Since January 3, 2011, the Company repurchased approximately 72,000 shares under a prior formal plan of repurchase.
Dynatronics expects to make the discretionary purchases with cash from operating activities and amounts available from its line of credit. At the present price of $.90 per share, the full repurchase would buy approximately 1,111,000 shares of stock, or approximately 8 percent of the company's outstanding shares. The purchases will be made at the discretion of management over an indefinite period and the program can be terminated at any time. The company is not obligated to make any purchases under the plan. Cullimore continued, "In authorizing this repurchase plan, our board of directors has expressed its judgment that a share repurchase program at this time is in the best interests of the company and its shareholders, and does not expect it to impact the company's ability to execute its growth plans."
Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, pain management, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other medical, cosmetic and aesthetic markets.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV